The presence of lysyl oxidase-like enzymes in human control and keratoconic corneas
- PMID: 26218558
- DOI: 10.14670/HH-11-649
The presence of lysyl oxidase-like enzymes in human control and keratoconic corneas
Abstract
Purpose: Lysyl oxidases, a family comprising lysyl oxidase (LOX) and four LOX-like enzymes (LOXL1-4), catalyse the cross-linking of elastin and collagen fibrils. Keratoconus (KC) is characterized by progressive thinning leading to irregular astigmatism, resulting in significant visual impairment. Although the pathogenesis of KC remains unclear, one of the current hypotheses is based on alterations in the organization and structure of collagen fibrils. To extend existing general knowledge about cross-linking enzymes in the human cornea, in the present study we have focused on the detection of LOXL enzymes.
Method: The localization and distribution of LOXL1-4 were assessed in cryosections of 7 control donors (three males and three females; 25-68 years; mean age 46±17.6 years) and 8 KC corneas (5 males and 3 females; 25-46 years; mean age 31.3±7.5 years) using indirect fluorescent immunohistochemistry (IHC). The specimens were examined using an Olympus BX51 microscope (Olympus Co., Tokyo, Japan) at a magnification of 200-1000x. Western blot analysis of 4 control and 4 KC corneas was performed for all tested enzymes.
Results: All four LOX-like enzymes were present in all layers of control corneas as well as in the limbus and conjunctiva. Almost no differences between control and pathological specimens were found for LOXL1. A lower staining intensity of LOXL2 was found using IHC and Western blot analysis in KC specimens. Decreases of the signal and small irregularities in the staining were found in the epithelium, keratocytes and extracellular matrix, where a gradual anterior-posterior weakening of the signal was observed. LOXL3 IHC staining was lower in the corneal stromal extracellular matrix and keratocytes of KC samples. No prominent differences were detected using IHC for LOXL4, but a slight decrease was observed in KC corneas using Western blot analysis.
Conclusion: We presume that the decrease of LOXL2 in KC corneas is more likely a consequence of the associated pathological processes (activation of stromal cells due to tissue weakening and consequent structural changes) than a direct cause leading to KC development. At this time, we are unable to provide a coherent explanation for the observed decrease of LOXL3 and LOXL4 in KC corneas.
Similar articles
-
Changes in lysyl oxidase (LOX) distribution and its decreased activity in keratoconus corneas.Exp Eye Res. 2012 Nov;104:74-81. doi: 10.1016/j.exer.2012.09.005. Epub 2012 Oct 3. Exp Eye Res. 2012. PMID: 23041260
-
Attenuation of lysyl oxidase and collagen gene expression in keratoconus patient corneal epithelium corresponds to disease severity.Mol Vis. 2015 Jan 12;21:12-25. eCollection 2015. Mol Vis. 2015. PMID: 25593510 Free PMC article. Clinical Trial.
-
An Evaluation of Lysyl Oxidase-Derived Cross-Linking in Keratoconus by Liquid Chromatography/Mass Spectrometry.Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):126-36. doi: 10.1167/iovs.15-18105. Invest Ophthalmol Vis Sci. 2016. PMID: 26780316 Free PMC article.
-
The impairment of lysyl oxidase in keratoconus and in keratoconus-associated disorders.J Neural Transm (Vienna). 2013 Jun;120(6):977-82. doi: 10.1007/s00702-013-0993-1. Epub 2013 Feb 20. J Neural Transm (Vienna). 2013. PMID: 23653221 Review.
-
Variation in the lysyl oxidase (LOX) gene is associated with keratoconus in family-based and case-control studies.Invest Ophthalmol Vis Sci. 2012 Jun 28;53(7):4152-7. doi: 10.1167/iovs.11-9268. Invest Ophthalmol Vis Sci. 2012. PMID: 22661479 Free PMC article. Review.
Cited by
-
Role of Lysyl Oxidase-Like Protein 3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.Invest Ophthalmol Vis Sci. 2024 Nov 4;65(13):33. doi: 10.1167/iovs.65.13.33. Invest Ophthalmol Vis Sci. 2024. PMID: 39546293 Free PMC article.
-
Untargeted Tear Proteomics in a Large South-Asian Cohort Reveals Inflammatory Signaling, ECM Remodeling, and Altered Metabolism in Keratoconus.Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):60. doi: 10.1167/iovs.66.2.60. Invest Ophthalmol Vis Sci. 2025. PMID: 39992672 Free PMC article.
-
Corneal Regeneration Using Gene Therapy Approaches.Cells. 2023 Apr 28;12(9):1280. doi: 10.3390/cells12091280. Cells. 2023. PMID: 37174680 Free PMC article. Review.
-
Systematically Displaying the Pathogenesis of Keratoconus via Multi-Level Related Gene Enrichment-Based Review.Front Med (Lausanne). 2022 Jan 24;8:770138. doi: 10.3389/fmed.2021.770138. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35141241 Free PMC article.
-
Keratoconus patients exhibit a distinct ocular surface immune cell and inflammatory profile.Sci Rep. 2021 Oct 22;11(1):20891. doi: 10.1038/s41598-021-99805-9. Sci Rep. 2021. PMID: 34686755 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases